author-photo

Eduardo Castanon

University of Navarra

72

Papers

790

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS12-07: Lenvatinib plus pembrolizumab for previously treated, advanced triple-negative breast cancer: Early results from the multicohort phase 2 LEAP-005 study

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Paradigms on Immunotherapy Combinations with Chemotherapy.

2021 Cancer Discovery
Show All
- Source
- Cite
- Save
Citations (16)
Abstract CT233: Phase 2 clinical study to evaluate the efficacy and safety of intratumoral BO-112 in combination with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

2021 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Critical reappraisal of phase III trials with immune checkpoint inhibitors in non-proportional hazards settings.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Cutaneous squamous cell carcinoma presenting with facial paralysis: good response to Cemiplimab.

2020 Journal Der Deutschen Dermatologischen Gesellschaft
Show All
- Source
- Cite
- Save
Citations (2)
A Trial of Lopinavir-Ritonavir in Covid-19.

2020 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Does active smoking worsen Covid-19?

2020 European Journal of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (5)
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

2020 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (13)
MET receptor amplification drives resistance to Anti-EGFR therapies

2019
Show All
- Source
- Cite
- Save
Citations (0)